Chemical activators of Spi13 include a range of compounds that influence cellular mechanisms leading to its activation. Dichloroacetic acid activates pyruvate dehydrogenase kinase which in turn activates the pyruvate dehydrogenase complex. The increased activity of this complex raises acetyl-CoA levels, which can enhance the acetylation of Spi13, thereby activating the protein. Trichostatin A, by inhibiting histone deacetylases, leads to hyperacetylation. This alteration in acetylation status can modify the interaction of Spi13 with chromatin or other proteins, resulting in its activation. Similarly, Vorinostat's inhibition of histone deacetylases may also lead to the activation of Spi13 due to changes in the acetylation of histones or associated proteins. Sodium butyrate operates through a comparable mechanism as a histone deacetylase inhibitor, potentially increasing the acetylation of histones near the Spi13 gene and activating the protein.
In addition to these, azacytidine and 5-Azacytidine, by inducing DNA demethylation, can facilitate Spi13 activation. Hypomethylation of the Spi13 gene promoter potentially leads to its increased expression and consequent protein activation. Resveratrol activates sirtuins that can deacetylate lysine residues on Spi13, which might result in activation of the protein through a change in its structure. Disulfiram's ability to chelate zinc ions could disrupt the function of zinc finger transcription factors that normally repress Spi13, leading to its activation. Epigallocatechin gallate and Zebularine both act as inhibitors of DNA methyltransferases, which could result in the activation of Spi13 due to hypomethylation of its gene. S-Adenosylmethionine, as a methyl donor, can activate Spi13 by methylation of proteins that repress Spi13 or its interaction partners. Dimethyl sulfoxide has the ability to permeabilize cell membranes, which may facilitate the activation of Spi13 by increasing the intracellular availability of other compounds that can directly activate the protein.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Dichloroacetic acid | 79-43-6 | sc-214877 sc-214877A | 25 g 100 g | $61.00 $128.00 | 5 | |
Dichloroacetic acid activates pyruvate dehydrogenase kinase, leading to the activation of pyruvate dehydrogenase complex which can increase the acetyl-CoA levels, enhancing the acetylation of Spi13, thus activating it. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
Trichostatin A inhibits histone deacetylases, leading to hyperacetylation, which can result in the activation of Spi13 by altering its interaction with chromatin or other proteins. | ||||||
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
Azacytidine induces DNA demethylation and can cause hypomethylation of Spi13 gene promoter, leading to increased expression and subsequent activation of Spi13 protein. | ||||||
Resveratrol | 501-36-0 | sc-200808 sc-200808A sc-200808B | 100 mg 500 mg 5 g | $80.00 $220.00 $460.00 | 64 | |
Resveratrol activates sirtuins which can lead to the deacetylation of lysine residues on Spi13, potentially activating it through a conformational change. | ||||||
Disulfiram | 97-77-8 | sc-205654 sc-205654A | 50 g 100 g | $53.00 $89.00 | 7 | |
Disulfiram can chelate zinc ions, potentially disrupting zinc finger transcription factors that repress Spi13 expression, leading to its activation. | ||||||
Suberoylanilide Hydroxamic Acid | 149647-78-9 | sc-220139 sc-220139A | 100 mg 500 mg | $133.00 $275.00 | 37 | |
Vorinostat inhibits histone deacetylases, potentially leading to increased acetylation and activation of Spi13. | ||||||
Sodium Butyrate | 156-54-7 | sc-202341 sc-202341B sc-202341A sc-202341C | 250 mg 5 g 25 g 500 g | $31.00 $47.00 $84.00 $222.00 | 19 | |
Sodium butyrate acts as a histone deacetylase inhibitor, which may enhance acetylation of histones around the Spi13 gene, promoting its activation. | ||||||
(−)-Epigallocatechin Gallate | 989-51-5 | sc-200802 sc-200802A sc-200802B sc-200802C sc-200802D sc-200802E | 10 mg 50 mg 100 mg 500 mg 1 g 10 g | $43.00 $73.00 $126.00 $243.00 $530.00 $1259.00 | 11 | |
Epigallocatechin gallate inhibits DNA methyltransferases, which could lead to hypomethylation and activation of the Spi13 gene. | ||||||
Zebularine | 3690-10-6 | sc-203315 sc-203315A sc-203315B | 10 mg 25 mg 100 mg | $129.00 $284.00 $1004.00 | 3 | |
Zebularine acts as a DNA methyltransferase inhibitor, potentially leading to the activation of Spi13 by hypomethylation of its promoter. | ||||||
Ademetionine | 29908-03-0 | sc-278677 sc-278677A | 100 mg 1 g | $184.00 $668.00 | 2 | |
S-Adenosylmethionine serves as a methyl donor for transmethylation reactions and may activate Spi13 by methylation of repressor proteins or interaction partners. | ||||||